A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
Clinical trial NCT04183686 · COMPLETED
Trial details
- NCT number
- NCT04183686
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-25
- Primary completion
- 2020-03-15
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.